A distinguished panel of researchers and clinicians will gather for a Continuing Medical Education (CME) symposium on Friday, January 31, 2025, to explore one of the most talked-about and often misunderstood topics in healthcare today—kratom.
The symposium, hosted by the Tulane University Center for Continuing Education, will take place in New Orleans and will also be available virtually. It will feature leading experts in pharmacology, toxicology, addiction medicine, and psychiatry, examining the latest scientific research and clinical experiences surrounding kratom use.
Event Details
Date: Friday, January 31, 2025
Time: 12:00 PM – 4:00 PM CST
In-person location: Tulane Tidewater Building, 1440 Canal St, New Orleans, LA 70112
Virtual location: Tulane University Center for Continuing Education
ME credit: Up to 3.5 AMA PRA Category 1 Credits™
Complimentary registration: Click here to register.
Time: 12:00 PM – 4:00 PM CST
In-person location: Tulane Tidewater Building, 1440 Canal St, New Orleans, LA 70112
Virtual location: Tulane University Center for Continuing Education
ME credit: Up to 3.5 AMA PRA Category 1 Credits™
Complimentary registration: Click here to register.
Expert-Led Discussions on Kratom’s Impact
With kratom use becoming more widespread in the U.S., healthcare professionals face increasing questions about its safety, potential benefits, and risks. This symposium provides a rare opportunity for clinicians and researchers to hear directly from nationally recognized experts studying kratom’s pharmacology, clinical implications, and potential benefits and risks.
With kratom use becoming more widespread in the U.S., healthcare professionals face increasing questions about its safety, potential benefits, and risks. This symposium provides a rare opportunity for clinicians and researchers to hear directly from nationally recognized experts studying kratom’s pharmacology, clinical implications, and potential benefits and risks.
Featured Speakers
- Dr. Christopher McCurdy, Associate Dean for Faculty Development, Frank A. Duckworth Eminent Scholar Chair, Professor of Medicinal Chemistry, and Director of the UF CTSI Translational Drug Development Core at the University of Florida. Dr. McCurdy’s pioneering research explores kratom’s pharmacology, its potential therapeutic uses, and the critical role of dosing in research and policy.
- Dr. Oliver Grundmann, Assistant Dean and Clinical Professor at the University of Florida. Dr. Grundmann is a leading expert on kratom consumer trends, providing insight into who is using kratom, why, and the clinical implications of these patterns.
- Dr. John Thompson, Chairman and Professor of the Department of Psychiatry and Behavioral Sciences at Tulane University School of Medicine. Dr. Thompson and faculty members from Tulane’s psychiatry department will present real-world case studies from their work in emergency medicine, addiction treatment, pain management, and psychiatric care.
Learner Objectives
After participating in this symposium, attendees should be better able to:
- Identify historical and indigenous uses of kratom for pain, sleep, and opioid replacement disorders.
- Describe current kratom usage trends in the U.S., including administration routes, servings, and consumer access.
- Discuss problematic kratom use, including common emergency room, addiction clinic, and pain practice presentations.
- Suggest legislative solutions to enhance safety.
Accreditation and CME Details
Tulane University Health Sciences Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Tulane University Health Sciences Center designates this live educational activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is presented for educational purposes only and does not endorse any product, content, or exhibit. Participants are expected to apply their own expertise and clinical judgment while engaging in medical practice.
Who Should Attend?
Designed for physicians, psychiatrists, healthcare professionals, addiction specialists, toxicologists, pain management specialists, pharmacists, researchers, and policymakers, this symposium will provide evidence-based discussions on kratom’s risks, potential benefits, and risks.
The Global Kratom Coalition is an alliance of kratom consumers, experts, and industry leaders dedicated to protecting access to kratom while advancing scientific research, driving consumer education, and developing robust regulations to protect consumers.
.jpeg)